Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
29.50
+0.80 (2.79%)
Dec 5, 2025, 4:00 PM EST - Market closed
Rapport Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 28.38 | 22.12 | 8.18 | 1.37 |
| Research & Development | 81.73 | 60.94 | 28 | 4.49 |
| Operating Expenses | 110.11 | 83.06 | 36.18 | 5.85 |
| Operating Income | -110.11 | -83.06 | -36.18 | -5.85 |
| Interest Expense | - | - | - | -0.31 |
| Interest & Investment Income | 12.41 | 12.14 | 2.53 | - |
| EBT Excluding Unusual Items | -97.7 | -70.92 | -33.65 | -6.17 |
| Other Unusual Items | - | -7.39 | -1.12 | - |
| Pretax Income | -97.7 | -78.31 | -34.78 | -11.62 |
| Income Tax Expense | - | - | 0.01 | - |
| Net Income | -97.7 | -78.31 | -34.79 | -11.62 |
| Net Income to Common | -97.7 | -78.31 | -34.79 | -11.62 |
| Shares Outstanding (Basic) | 36 | 21 | 2 | 1 |
| Shares Outstanding (Diluted) | 36 | 21 | 2 | 1 |
| Shares Change (YoY) | 190.80% | 1277.25% | 93.74% | - |
| EPS (Basic) | -2.72 | -3.78 | -23.10 | -14.95 |
| EPS (Diluted) | -2.72 | -3.78 | -23.10 | -14.95 |
| Free Cash Flow | -77.89 | -67.23 | -28.82 | -3.85 |
| Free Cash Flow Per Share | -2.17 | -3.24 | -19.14 | -4.95 |
| EBITDA | -109.1 | -82.22 | -36.07 | -5.84 |
| D&A For EBITDA | 1.01 | 0.84 | 0.11 | 0.02 |
| EBIT | -110.11 | -83.06 | -36.18 | -5.85 |
Source: S&P Capital IQ. Standard template.
Financial Sources.